Literature DB >> 18955960

Cholinesterase inhibitors and memantine: best practices.

Rachelle S Doody1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18955960     DOI： 10.1017/s1092852900027048

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  4 in total

1.  Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease.

Authors:  Maria Carmela Tartaglia; Bei Hu; Kala Mehta; John Neuhaus; Kristine Yaffe; Bruce L Miller; Adam Boxer
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

2.  Off-label medication use in frontotemporal dementia.

Authors:  Leslie Ross; John Neuhaus; David Knopman; Joel Kramer; Bradley Boeve; Richard J Caselli; Neill Graff-Radford; Mario F Mendez; Bruce L Miller; Adam L Boxer
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-02-01       Impact factor: 2.035

3.  Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Authors:  Bruno P Imbimbo; Vincenzo Solfrizzi; Francesco Panza
Journal:  Front Aging Neurosci       Date:  2010-05-21       Impact factor: 5.750

4.  Using nonevidence-based approaches to treat patients with alzheimer's disease.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2009-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.